期刊文献+

重组人成熟型转化生长因子β_1及其抗原表位在大肠杆菌中的表达、纯化及其免疫原性鉴定

Expression of Recombinant Human Mature TGF-β_1 and Its Antigen Epitopes in E. coli and Purification and Immunogenicity of Expressed Product
下载PDF
导出
摘要 目的研制人转化生长因子(TGF)-β1自体蛋白疫苗,并诱导小鼠产生抗人TGF-β1的中和抗体。方法将hTGF-β1及其抗原表位基因β32和β80分别克隆入pGEX-4T-1原核表达载体,并引入T细胞辅助表位(TT),转化大肠杆菌,经IPTG诱导表达。应用GST亲和层析纯化重组融合蛋白,并经Westernb lot鉴定,用流式细胞术(FCM)检测抗hTGF-β1抗血清与人肝癌细胞株SMMC-7721表面膜型TGF-β1的结合状况。用纯化蛋白免疫BALB/c小鼠,通过ELISA检测血清中抗hTGF-β1抗体的效价。结果成功构建了人成熟型TGF-β1及其不同表位基因片段的重组表达质粒pGEX-TT-β32、pGEX-TT-β80和pGEX-TT-hTGF-β1,表达的3种重组蛋白(GST-TT-β32、GST-TT-β80和GST-TT-hTGF-β1)经Western blot鉴定显示,同时具有hT-GF-β1和GST的抗原性。经纯化后免疫BALB/c小鼠,血清抗人TGF-β1抗体的效价均达到1∶104,其中GST-TT-β80的抗体效价最高。FCM显示3种重组蛋白免疫的小鼠抗血清均能与高表达膜型TGF-β1的人SMMC-7721结合,但重组蛋白GST-TT-β80和GST-TT-hTGF-β1免疫组抗血清的结合率明显高于GST-TT-β32组。结论构建的人成熟型TGF-β1及其不同表位片段的不同融合蛋白疫苗均能够诱导BALB/c小鼠产生抗人TGF-β1的中和抗体。 Objective To prepare human transforming growth factor(TGF) -β1 autogenous vaccine and induce neutralizing antibedy against human TGF-β1 in mice. Methods Clone the gene fragments encoding human mature TGF-β1 and its antigen epitopes β32 and β80 into prokaryotic expression vector pGEX-4T-1 ,with a tetanus toxoid epitope introduced, respectively. Transform the constructed recombinant plasmids to E. coli for expression under induction of IPTG. Purify the expressed protein by GST affinity chromatography and identify by Western blot. Immunize BALB/c mice with the purified protein and determine the titers of neutrazlizing antibody against hTGF-β1 in sere by ELISA. Test the binding of antisem against hTGF-β1 to the TGF-β1 on surface membrane of human hepatoma cell SMMC-7721 strain by flow cytometry ( FCM ). Results Recombinant plasmids pGEX-TF-β32, pGEX-TF-β80 and pGEX-TF-hTGF-β1 were successfully constructed, and recombinant proteins CST-TT-β32, GST-TT-β80 and GST-TT-hTGF-β1 were expressed and showed beth antigenicities of hTGF-β1 and GST as proved by Western blot. All the serum neutralizing antibody titers against human TGF-β1of immunized mice were not less than 1:10 000,of which the titer induced by GST-TT-β80 was the highest. FCM proved that all the three kinds of recombinant proteins bound to the TGF-β1 on surface membrane of SMMC-7721 cells. However,the binding rates of GST-TT- β80 and C, ST-TT-hTGF-β1 were significantly higher than that of GST-TT-β32. Conclusion The expressed fusion proteins induced neu- tralizing antibody against human TGF-β1 in mice and might be the candidates of human TGF-β1 autogenous vaccine.
出处 《中国生物制品学杂志》 CAS CSCD 2007年第2期77-80,共4页 Chinese Journal of Biologicals
基金 教育部"长江学者和创新团队发展计划"(IRT0459)肿瘤生物学国家重点实验室
关键词 转化生长因子 抗原表位 自体疫苗 Transforming growth factor(TGF) Antigen epitope Autogenons vaccine
  • 相关文献

参考文献9

  • 1Mishra L,Derynck R,Mishra B.Transforming growth factor-beta signaling in stem cells and cancer.Science,2005,310 (5745):68 -71.
  • 2Heldin CH,Miyazono K,Ten Dijke P.TGF-beta signalling from cell membrane to nucleus through SMAD proteins.Nature,1997,390(6659):465-471.
  • 3Derynck R,Akhurst RJ,Balmain A.TGF-beta signaling in tumor suppression and cancer progression.Nature Genet,2001,29 (2):117-129.
  • 4姜昌丽,张英起,颜真.重组人TGF-β1融合蛋白的克隆、表达、纯化及鉴定[J].第四军医大学学报,2006,27(3):193-195. 被引量:4
  • 5Fehérvari Z,Sakaguchi S.CD4^ + Tregs and immune control.Clin Invest,2004,114(9):1209-1217.
  • 6Ghiringhelli F,Menard C,Terme M,et al.CD4^ + CD25^ + regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner.J Exp Med,2005,202 (8):1075-1085.
  • 7Fu S,Zhang N,Yopp AC,et al.TGF-beta induces Foxp3^ + T-regulatory cells from CD4 + CD25-precursors.Am J Transplant,2004,4(10):1614-1627.
  • 8Arteaga CL,Hurd SD,Winner AR,et al.Anti-transforming growth factor(TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen nature killer cell activity.J Clin Invest,1993,92 (6):2569 -2576.
  • 9Henderson RA,Mossman S,Nairn N,et al.Cancer vaccines and immunotherapies:emerging perspectives.Vaccine,2005,23 (17-18):2359-2362.

二级参考文献8

  • 1Mishra L,Derynck R,Mishra B.Transforming growth factor-{beta} signaling in stem cells and cancer[J].Science,2005,310(5745):68-71.
  • 2Heldin CH,Miyazono K,ten Dijke P.TGF-beta signalling from cell membrane to nucleus through SMAD proteins[J].Nature,1997,390(6659):465-471.
  • 3Derynck R,Akhurst RJ,Balmain A.TGF-beta signaling in tumor suppression and cancer progression[J].Nature Genet,2001,29(2):117-129.
  • 4Derynck R,Jarrett JA,Chen EY,et al.Human transforming growth factor-beta complementary DNA sequence and expression in normal and transformed cells[J].Nature,1985,316(6030):701-705.
  • 5Platten M,Wild-bode C,Wick W,et al.N-[3,4-dimethoxycinnamoyl]-anthranilic acid (tranilast) inhibit transforming growth factor-beta release and reduces migration and invasiveness of human malignant glioma cell[J].Int J Cancer,2001,93(1):53-61.
  • 6Wojtowictz-Praga S,Verma UN,Wakefield L,et al.Modulation of B16 melanoma growth and metody and interleukin-2[J].J Immunother,1996,19(3):169-175.
  • 7Arteaga CL,Hurd SD,Winner AR,et al.Anti-transforming growth factor (TGF)-β antibodies inhibit breast cancer cell tumorigenicity and increase mouse spleen nature killer cell activity[J].J Clin Invest,1993,92(6):2569-2576.
  • 8苏海川,赵玉红,张惠中,范清宇.肿瘤坏死因子凋亡相关配体基因的克隆和表达[J].第四军医大学学报,2003,24(16):1482-1484. 被引量:2

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部